PropertyValue
?:abstract
  • The objective of the article was to provide guidance on the application of non-pharmaceutical countermeasures to minimize the spread of the 2019 novel Coronavirus (2019-nCoV) in the population Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can be adapted depending on the assessed severity/impact of the infection The guidelines are based on the current knowledge of the 2019-nCoV and evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV) and seasonal or pandemic influenza viruses
?:creator
?:journal
  • Guidelines_for_use_of_non_pharmaceutical_measures_to_delay_and_mitigate_impact_of
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV
?:type
?:who_covidence_id
  • #1016627
?:year
  • 2019

Metadata

Anon_0  
expand all